3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rhabdomyosarcoma
6
Wilms Tumor
3
Rhabdomyosarcoma, Embryonal
3
Sarcoma
2
Rhabdomyosarcoma, Alveolar
2
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Alveolar Soft Part
1
Pleuropulmonary blastoma
1
Hydatidiform Mole, Invasive
1
Histiocytoma, Malignant Fibrous
1
Gestational Trophoblastic Disease
1
Dermatofibrosarcoma
1
Choriocarcinoma
1
Beckwith-Wiedemann Syndrome
1
Interventions
Cyclophosphamide
43
venetoclax
30
Cytarabine
25
fludarabine
22
fludarabine phosphate
17
Azacitidine
16
Mycophenolic Acid
13
Whole-Body Irradiation
12
Dexamethasone
12
Rituximab
11
Busulfan
11
ruxolitinib
10
Vincristine
10
Methotrexate
10
Etoposide
10
Tacrolimus
9
Mercaptopurine
9
Daunorubicin
9
Prednisone
8
Filgrastim
8
Dasatinib
8
ibrutinib
7
Peripheral Blood Stem Cell Transplantation
7
Melphalan
7
Granulocyte Colony-Stimulating Factor
7
Doxorubicin
7
Decitabine
7
pegaspargase
6
blinatumomab
6
Mesna
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Dactinomycin
×
1 year
×
Clear all
No trials found.